Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionSun Pharma's investors face a risk from India's unbranded generic drug push

    Sun Pharma's investors face a risk from India's unbranded generic drug push

    Its large presence in India's branded generic drug market exposes it the most to a risk from trade generics. But other major pharma companies are at risk too

    R. Sree Ram
    August 16, 2023 / 09:03 IST
    Pharmacy
    • PRO Panorama

      Moneycontrol Pro Panorama | Fintechs are quietly winning the retail loan race

      Nov 19, 2025 / 03:38 PM IST

      Moneycontrol's Pro Panorama November 19 edition: A silent shift is underway in India’s credit landscape, with fintechs pulling a...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts